Who Should Attend: Member of Research Institutions, Government bodies, NGOs, International Organizations and Academies and Pharmaceutical R and D
Day 1: Vector Control: Research, Economics and Policy
The WHO estimations on the burden of malaria do not fully reflect the availability of new tools to fight the diseases nor the multiplicity of parasitological, epidemiology and treatment research- as well as the new thinking on financing- that have been taken place in the last decade. In fact 219 million cases of malaria occur every year around the world and 660.000 people still die - mainly in children under the age of 5. Moreover, it is evident that current funding levels do not allow for full implementation of the newest and most effective interventions globally: The Roll Back Malaria Partnership estimates that an annual funding gap of about $2.8 billion will need to be filled in order to to reduce its incidence by 75% and malaria deaths to zero by 2015. This session aims at understanding the scientific, economic and political implications behind the opportunities and hurdles to stop this killing disease and to achieve the Millennium Development Goals targets.
Day 2: Immunology and Vaccination
This session will discuss the mechanisms of immunity and immunopathology in order to facilitate vaccine design and the identification of additional therapies for treatment of severe malaria. There will be plenty of opportunities for debate and networking.
The prevention of anti-malarial drug resistance is of enormous public health importance. It can be assumed that no therapy currently under development or to be developed in the foreseeable future will be totally protective against malaria. This session will discuss the development of new treatments for malaria together with the use of current drugs to limit, insofar as it is possible, any further development of resistance. There will be plenty of opportunity for delegates to present their work and network in an informal atmosphere, with a lot of time given for discussion and debate.
Phone: (+44) 07507 799380
To download the accommodation and travel details please click here
An event from European Scientific Conferences - Euroscicon "Specialising in communicating cutting edge technology & methodology in the Life Sciences"
EuroSciCon Ltd. Registered in England and Wales,
Company number: 4326921, Registered Office: 47 Falkland Road, High Barnet, EN5